Calcium, vitamin D, and risk: Authors' reply

BMJ

Volumn 342, Issue 7810, 2011, Pages

  Bolland, Mark J ^a   Avenell, Alison ^b   Grey, Andrew ^a   Gamble, Greg D ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

BLOOD PRESSURE MEASUREMENT; BODY MASS; CALCIUM INTAKE; CARDIOVASCULAR RISK; HEART INFARCTION; HUMAN; INCIDENCE; LETTER; PRIORITY JOURNAL; STROKE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 79958703448     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d3544     Document Type: Letter

References (8)

1. Black SL. Analysis of absolute incidence tells different story. BMJ 2011;342:d3530.
2. Metcalfe AV, Nordin BEC. A reanalysis too far? BMJ 2011;342:d3538
3. Bolland MJ, Grey A, Reid IR. Calcium supplements and cardiovascular risk. J Bone Miner Res 2011;26:899.
4. Prince RL, Zhu K, Lewis JR. Evidence of harm is unconvincing. BMJ 2011;342:d3541.
5. Penston J. Claims do not hold water. BMJ 2011;342:d3543.
6. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355:1064-9. (Pubitemid 30162810)
7. Lagakos SW. The challenge of subgroup analyses - reporting without distorting. N Engl J Med 2006;354:1667-9.
8. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357:2189-94.